Old Web
English
Sign In
Acemap
>
authorDetail
>
Yoshimasa Matsuura
Yoshimasa Matsuura
Chugai Pharmaceutical Co.
HER2 negative
Oncology
Metastatic breast cancer
Internal medicine
Medicine
2
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer
2017
Breast Cancer Research and Treatment
Hiroji Iwata
Norikazu Masuda
Daigo Yamamoto
Yoshiaki Sagara
Nobuaki Sato
Yutaka Yamamoto
Mitsue Saito
Takashi Fujita
Shoji Oura
Junichiro Watanabe
Masami Tsukabe
Kazumi Horiguchi
Satoshi Hattori
Yoshimasa Matsuura
Katsumasa Kuroi
Show All
Source
Cite
Save
Citations (9)
Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial
2017
Breast Cancer Research and Treatment
Daigo Yamamoto
Nobuaki Sato
Yoshiaki Rai
Yutaka Yamamoto
Mitsue Saito
Hiroji Iwata
Norikazu Masuda
Shoji Oura
Junichiro Watanabe
Satoshi Hattori
Yoshimasa Matsuura
Katsumasa Kuroi
Show All
Source
Cite
Save
Citations (6)
1